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Abstract 
Breast milk is a complex liquid rich in immunological components that affect the development 
of the infant’s immune system. Exosomes are membranous vesicles of endocytic origin that 
are found  in various  body  fluids and that can mediate  intercellular  communication. Mi-
croRNAs (miRNAs), a well-defined group of non-coding small RNAs, are packaged inside 
exosomes in human breast milk. Here, we identified 602 unique miRNAs originating from 452 
miRNA precursors (pre-miRNAs) in human breast milk exosomes using deep sequencing 
technology. We found that, out of 87 well-characterized immune-related pre-miRNAs, 59 
(67.82%) are presented and enriched in breast milk exosomes (P < 10
-16, 
2 test). In addition, 
compared with exogenous synthetic miRNAs, these endogenous immune-related miRNAs 
are more resistant to relatively harsh conditions. It is, therefore, tempting to speculate that 
these exosomal miRNAs are transferred from the mother’s milk to the infant via the digestive 
tract, and that they play a critical role in the development of the infant immune system. 
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Introduction 
The past decade has seen a large increase in the 
list of immunological components detected in human 
breast milk [1]. Large quantities of secretory immu-
noglobulins  (particularly  IgA),  measurable  levels  of 
leukocytes, as well as antimicrobial factors (such as 
lysozyme,  lactoferrin  and  oligosaccharides)  are 
abundant  in  breast  milk  [2].  These  immune-related 
factors not only provide passive immunity to infants, 
but could also prompt and modulate the development 
of the infant’s own immune system. 
Exosomes are tiny endosome-derived membrane 
vesicles  (~30-100  nm  in  diameter)  that  are  released 
into the extracellular environment from a variety of 
different cells [3, 4]. Exosomes are present in various 
body fluids (such as amniotic fluid, blood, malignant 
ascites fluid, milk, saliva and urine) and contain dis-
tinct subsets of microRNAs (miRNAs) [5]. miRNAs, a 
large family of ~22 nucleotide (nt) non-coding small 
RNAs, are derived from ~70 nt long stem-loop pre-
cursors  (pre-miRNAs),  have  emerged  as  key 
post-transcriptional regulators of gene expression and 
play important roles in a wide range of physiological 
and  pathological  processes  [6].  Circulating  miRNA 
levels  have  been  found  to  be  elevated  in  diseased 
states, such as ovarian cancer, lung cancer and mela-
noma [7-9]. The finding that miRNAs are present in 
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exosomes triggered the hypothesis that extracellular 
miRNAs may function in cell-cell communication [4, 
10]. 
In the present study, we investigated the miRNA 
transcriptome of exosomes in human breast milk us-
ing deep sequencing technology to elucidate the dis-
tribution  and  expression  profile  of  immune-related 
miRNAs. Particular emphasis was placed on the re-
sistance and stability of breast milk miRNAs under 
different harsh conditions. 
Materials and Methods 
Ethics statement 
All  women  involved  in  the  study  gave  their 
signed informed consent to participate. The study was 
approved  by  the  ethics  committees  of  Ya’an  Voca-
tional College and the College of Animal Science and 
Technology, Sichuan Agricultural University. 
Sample collection 
Human  breast  milk  samples  (20-50  ml)  were 
collected  into  sterile  tubes  using  a  manual  breast 
pump from four healthy women (30 ± 0.9 years old, 
primiparity)  when  their  infants  were  aged  60  days. 
Smoking  or  medication  during  pregnancy,  known 
autoimmune  disorders,  diabetes,  or  allergic  asthma 
excluded women from participation in this study. All 
samples  were  stored  at  -80  °C  until  analyzed.  All 
mothers had full term vaginal deliveries of healthy, 
normal birth-weight infants. 
Enrichment of exosomal RNA in breast milk 
Raw milk (1.5 ml) was centrifuged at 2,000 × g 
for 10 min to remove fat globules. The supernatant 
was centrifuged at 12,000 × g for 30 min and further 
filtered  through  a  0.45  μm  PVDF  filter  to  eliminate 
cells and cellular debris. Approximately 1 ml of su-
pernatant was mixed with 500 µl of ExoQuick Exo-
some Precipitation Solution (SBI, CA, USA) and in-
cubated  at  4  °C  for  12  hours.  The 
ExoQuick/supernatant  mixture  was  centrifuged  at 
1,500 × g for 30 min to obtain a beige exosome pellet, 
which was then re-suspended in 250 µl nuclease-free 
water. Total RNA from exosomes was extracted using 
TRIzol-LS (Invitrogen, CA, USA) following the man-
ufacturer’s instructions. Small  RNAs were analyzed 
with the Agilent Bioanalyzer 2100 and the RNA 6000 
Nano LabChip Kit (Agilent, CA, USA). 
Small RNA sequencing 
Total RNA isolated from each woman’s milk was 
used  for  library  construction  and  subjected  to  sin-
gle-end sequencing in 36 bp reads using an Illumina 
Genome Analyzer II. The bioinformatics pipeline for 
miRNA  discovery  and  profiling  was  carried  out  as 
previously described [11, 12]. In brief, the raw reads 
that  passed  through  a  series  of  filters  (such  as  the 
length and sequence comparison) were called “map-
pable reads”. All mappable reads were counted and 
the identical reads were combined into a single kind, 
and  then  were  mapped  to  the  1,424  human 
pre-miRNAs registered in miRBase 17.0 (April 2011) 
with  no  more  than  one  mismatch.  As  our  previous 
reports [11, 12], the most abundant mature variant of a 
given  miRNA  was  chosen  as  a  reference  sequence, 
which provides the most robust approach for evalua-
tion of expression level. The small RNA sequence data 
from  this  study  have  been  submitted  to  the  NCBI 
Gene  Expression  Omnibus  under  accession  no. 
GSE32253. 
Harsh treatments of miRNAs and quantitative 
PCR (q-PCR) 
Three  exogenous  miRNAs  (ath-miR-159a-3p  of 
A. thaliana, cel-lin-4-5p and cel-miR-2-3p of C. elegans), 
which  have  no  sequence  similarity  to  human  miR-
NAs, were chemically synthesized. To determine the 
resistance  and  stability  of  exogenous  miRNAs, 
ath-miR-159a-3p was added directly to raw milk and 
subjected to four types of treatment: (1) incubated at 
26 °C for 0.5, 1, 2, 4, 8 and 24 hours; (2) subjected to six 
freeze-thaw cycles at -20 °C; (3) treated with RNase A 
(0.16  µg·µl-1)  and  RNase  T1  (0.4  U·µl-1)  (Fermentas, 
Shenzhen, China) for 60 min at 37 °C; and (4) incu-
bated at 100 °C for 10 min. After these treatments, in 
order to normalize inter-sample variation in the RNA 
isolation  step,  cel-lin-4-5p  and  cel-miR-2-3p  were 
added to the raw milk after the addition of TRIzol-LS 
(Invitrogen, CA, USA), which contains RNase inhibi-
tors. 
EvaGreen-based  q-PCR  was  performed  with  a 
High-Speciﬁcity  miRNA  qRT-PCR  Detection  Kit 
(Stratagene,  CA,  USA)  on  the  CFX96™  Real-Time 
PCR Detection System (Bio-Rad, CA, USA). The for-
ward primers of the three exogenous and ten endog-
enous miRNAs were identical in sequence and length 
to  the  miRNAs  themselves.  The  ΔΔCt  method  was 
used  to  determine  expression  level  differences  be-
tween surveyed samples. Each miRNA of each sample 
was analyzed in triplicate.  
Results and Discussion 
An overview of exosomal miRNAs in milk 
Four exosomal small RNA libraries were gener-
ated from the milk of four women and each library 




million (M) 36 nt reads. The four libraries produced 
~86.37 M raw reads and of these, 96.70% (~83.52 M) 
passed through filters for sequence patterns (simple 
sequence compositions) of length, copy number and 
other  known  RNA  classes,  and  are  referred  to  as 
“mappable reads” [11, 12]. Similar to previous studies 
on different tissue types [11, 12], the majority of the 
small RNAs in breast milk exosomes are 20-24 nt in 
size,  with  the  predominant  species  being  22  nt  in 
length  (65.56  ±  7.65%),  which  is  typical  of  Dic-
er-processed products (Fig. 1). 
 
 
Figure  1. Length distribution and frequency percent  of 
mappable reads. Values are means ± s.d. 
 
Analysis of the mapped human pre-miRNAs in-
dicates  that  452  of  1,424  (~31.74%)  known  human 
pre-miRNAs deposited in the latest version of miR-
Base 17.0 were detected in the four exosomal small 
RNA  libraries  (Fig.  2A).  Predictably,  we  detected 
identical  mature  miRNA  sequences  that  originate 
from  distinct  pre-miRNAs;  639  mature  miRNAs 
originating  from  452  pre-miRNAs  were  identified, 
corresponding to 602 unique miRNAs. 
The biological replicates were highly correlated 
with  each  other  (average r  =  0.94)  (Table  1),  which 
suggested  experimental  reliability  and  further 
highlighted  the  low  variation  in  exosomal  miRNA 
profiles  in  breast  milk  across  different  healthy 
individuals. 
 
Table 1. Pearson’s correlation of the counts of 602 unique 
miRNAs among four biological replicates. (**: P < 10
-16) 
Sample No.  2  3  4 
1  0.93**  0.95**  0.89** 
2    0.98**  0.94** 
3      0.96** 
 
Immune-related miRNAs are enriched in 
breast milk exosomes 
The  miRNA  transcriptome  in  breast  milk  exo-
somes  consists  of  unevenly  distributed  counts  of 
reads, varying from millions of reads for the highest 
expression  to  single  count  miRNAs.  The  ten  most 
highly expressed unique miRNAs account for 62.3 % 
of the total counts for all 602 unique miRNAs (Fig. 
2B).  
Notably,  four  of  the  top  ten  miRNAs  (1st: 
miR-148a-3p; 2nd: miR-30b-5p; 8th: miR-182-5p; and 9th: 
miR-200a-3p)  are  designated  as  immune-related 
pre-miRNAs based on the annotation of the Pathway 
Central  database  (SABiosciences,  MD,  USA). 
miR-30b-5p  promotes  cellular  invasion  and  immu-
nosuppression  [13];  miR-182-5p  is  induced  by  IL-2 
(interleukin-2) and promotes T cell-mediated immune 
responses  [14];  and  miR-200a-3p  is  associated  with 
Hodgkin lymphoma [15] and oral cancers [16]. Spe-
cifically, miR-148a-3p was the most highly expressed 
miRNA  over  all  four  libraries  and,  on  average,  ac-
counts  for  ~35.45  %  of  the  total  counts  of  all  602 
unique  miRNAs.  This  is  consistent  with  a  previous 
report  showing  that  miR-148a-3p  was  highly  ex-
pressed in bovine milk and was identified as a poten-
tial biomarker for the quality control of raw milk and 
other milk-related products [17]. Intriguingly, direct 
protein coding gene targets of miR-148a-3p so far re-
ported include TGIF2 (TGFB-induced factor homeo-
box 2), which is overexpressed in ovarian cancer [18] 
and PXR (pregnane X receptor), a major transcription 
factor regulating the inducible expression of a variety 
of transporters and drug-metabolizing enzymes [19]. 
Interestingly, DNMT3B (DNA methyltransferase 3b), 
which encodes a de novo methyltransferase that sets 
up DNA methylation patterns early in development, 
is  another  known  target  of  miR-148a  [20]. A  recent 
study showed that the exogenous plant miRNAs in 
food  are  present  in  the  sera  and  tissues  of  various 
animals,  and  can  regulate  the  expression  of  target 
genes  in  mammals  [21].  Therefore,  we  tentatively 
speculate  that  the  enrichment  of  these  highly  ex-
pressed  miRNAs  in  human  breast  milk  lead  to  a 
post-transcriptional repression of their target genes in 
cells of the infant digestive tract. 
Recent reports indicate that other miRNAs in the 
top  ten  are  also  related  to  various  pathological  re-
sponses.  For  example,  miR-29a-3p  suppresses  im-
mune responses to intracellular pathogens by target-
ing interferon-γ [22]; plasma miR-141-3p was identi-
fied as a potential biomarker for colon cancers [23]; 
miR-378-3p  acts  as  a  molecular  switch  involved  in 
breast cancer cell metabolism via interference with a 
well-integrated bioenergetics transcriptional pathway 
[24], and miR-146b-5p targets NF-κB signaling in in-
nate immune responses [25].  













   
Figure  2.  Distribution  and  characterization  of  miRNAs  in  breast  milk  exosomes.  (A)  Distribution  of 
pre-miRNAs. Out of 1,424 pre-miRNAs deposited in miRBase 17.0 (blue circle), 87 (6.11%) pre-miRNAs have been des-
ignated as immune-related pre-miRNAs based on annotation in the Pathway Central database (SABiosciences, MD, USA). 
Immune-related pre-miRNAs (59 of 452, 13.05%) are enriched in breast milk exosomes (red circle). 
2 test: Number of 
immune-related miRNAs and others detected in breast milk exosomes compared with the total entries in miRBase 17.0. (B) 
Top ten most highly expressed unique miRNAs. Plot of the unique miRNAs (starting from the miRNA with the highest 
counts, x-axis) versus their cumulative % of the total counts from 602 unique miRNAs detected in breast milk exosomes for 
each small RNA library. Values are means ± s.d. The dashed horizontal line at 62.3% represents the level of the top ten 
unique miRNAs and the % of individual miRNAs is marked by the gray line. (C-E) The expression profile of selected miRNAs 
in breast milk exosomes. (C) 59 immune-related pre-miRNAs; (D) miR-17-92 cluster and paralogous clusters, and (E) ten 
well-characterized tissue-specific pre-miRNAs. 





In addition, two of the top ten miRNAs are from 
the ubiquitous let-7-family of miRNAs (let-7f-1-5p & 
-2-5p, and let-7a-2-5p & -3-5p), which are key miRNA 
regulators in development that are present in abun-
dance  across  various  species,  including  mammals, 
flies, worms and plants [26]. 
The distribution of pre-miRNAs in breast milk 
exosomes  shows  that  more  than  half  of  the  im-
mune-related pre-miRNAs (59 of 87, 67.82%) are pre-
sent and enriched in breast milk exosomes (P < 10-16, 
2 test) (Fig. 2A, C), which is consistent with previous 
studies [27]. Interestingly, six pre-miRNAs from the 
miR-17-92 cluster and nine pre-miRNAs from paral-
ogous clusters were both abundant in breast milk ex-
osomes  (Fig.  2D).  In  addition  to  being  well-known 
oncogenes, recent studies establish essential roles for 
the  miR-17-92  and  paralogous  clusters  in  develop-
ment  of  the  immune  system  [28].  In  contrast,  tis-
sue-specific miRNAs were generally less abundant in 
breast milk exosomes (Fig. 2E).  
Previous reports suggested that exosomes play a 
significant  role  in  intercellular  communication  by 
transferring  miRNAs  to  neighboring  cells  [4,  10]. 
Although the molecular mechanism underlying this 
phenomenon is still unclear, it is intriguing to specu-
late that the these immune-related miRNAs in milk 
exosomes may be transferred into the infant body via 
the digestive tract, and may play a critical role in the 
development of the immune system in infants.  
Resistance to degradation and stability of 
breast milk miRNAs 
We  next  sought  to  investigate  the  stability  of 
miRNAs in breast milk, given that it is an important 
prerequisite  for  our  hypothesis  that  these  exosomal 
miRNAs  are  transferable  genetic  material  from 
mother to infant.  
Similar to previous studies on blood [29, 30], the 
exogenous synthetic miRNAs were rapidly degraded, 
whereas  endogenous  miRNAs  remain  stable  when 
milk is subjected to prolonged room temperature in-
cubation  (Fig.  3A)  or  freeze-thawed  multiple  times 
(Fig. 3B). Furthermore, compared with the complete 
degradation of exogenous miRNAs by treatment with 
RNase (Fig. 3C) or by incubation at 100°C for 10 min 
(Fig. 3D), the endogenous miRNAs are resistant to a 





     
Figure 3. Characterization of breast milk miRNAs. The expression changes of a spiked-in C. elegans miRNA and of 
the top ten most highly expressed unique miRNAs from the small RNA libraries across various harsh conditions. Total RNA 
was extracted and then analyzed by q-PCR. Breast milk was (A) incubated at 26°C for 0.5, 1, 2, 4, 8 or 24 hours, (B) sub-
jected to six freeze-thaw cycles at -20°C, (C) treated with RNase A and T1 for 60 min at 37°C, and (D) incubated at 100°C 
for 10 min. 






The present study provides a close look at the 
immune-related miRNAs which are enriched in breast 
milk  exosomes,  and  evidence  that  these  exosomal 
miRNAs  are  resistant  to  general  harsh  conditions, 
such  as  prolonged  room  temperature  incubation, 
multiple  freeze-thaw,  RNase  digestion  and  even 
boiling. We tentatively propose that these exosomal 
miRNAs  are  transferable  genetic  material  from 
mother to infant, and are essential for the develop-
ment of the immune system in infants. 
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